Last update 24 Jan 2026
Tollys

Tollys

Startups
| Holding Company|2015|France|
< 10
|
www.tollys.fr

Overview

Tags

Neoplasms
Immune System Diseases
Gene therapy
siRNA

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Immune System Diseases1
Top 5 Drug TypeCount
Gene therapy1
siRNA1
Top 5 TargetCount
RIG-I x TLR31
TLR3(Toll like receptor 3)1

Related

2
Drugs associated with Tollys
TL-532
Target
TLR3
Mechanism
TLR3 agonists
Active Org.
TollysTollys
Originator Org.
TollysTollys
Active Indication
Immune System Diseases
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Riboxxim
Target
RIG-I x TLR3
Mechanism
RIG-I modulators [+1]
Active Org.
Riboxx Pharmaceuticals [+1]
Originator Org.
Riboxx Pharmaceuticals
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Tollys
Login to view more data
0 Patents (Medical) associated with Tollys
Login to view more data
100 Deals associated with Tollys
Login to view more data
100 Translational Medicine associated with Tollys
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
TL-532
 ( TLR3 )		Immune System Diseases
More
Preclinical
Riboxxim
 ( RIG-I x TLR3 )		Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free